Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 310

1.

The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders.

Maddison P, Titulaer MJ, Verschuuren JJ, Gozzard P, Lang B, Irani SR, Sabater L, Graus F, Murray A, Chapman CJ.

J Neuroimmunol. 2018 Nov 8;326:14-18. doi: 10.1016/j.jneuroim.2018.11.003. [Epub ahead of print]

PMID:
30445363
2.

Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis.

Sabre L, Maddison P, Sadalage G, Ambrose PA, Punga AR.

J Neuroimmunol. 2018 Aug 15;321:164-170. doi: 10.1016/j.jneuroim.2018.05.003. Epub 2018 May 8.

3.

Distinct HLA associations of LGI1 and CASPR2-antibody diseases.

Binks S, Varley J, Lee W, Makuch M, Elliott K, Gelfand JM, Jacob S, Leite MI, Maddison P, Chen M, Geschwind MD, Grant E, Sen A, Waters P, McCormack M, Cavalleri GL, Barnardo M, Knight JC, Irani SR.

Brain. 2018 May 18. doi: 10.1093/brain/awy109. [Epub ahead of print]

4.

Seronegative antibody-mediated neurology after immune checkpoint inhibitors.

Wilson R, Menassa DA, Davies AJ, Michael S, Hester J, Kuker W, Collins GP, Cossins J, Beeson D, Steven N, Maddison P, Rinaldi S, Jacob S, Irani SR.

Ann Clin Transl Neurol. 2018 Mar 25;5(5):640-645. doi: 10.1002/acn3.547. eCollection 2018 May.

5.

MT-ND5 Mutation Exhibits Highly Variable Neurological Manifestations at Low Mutant Load.

Ng YS, Lax NZ, Maddison P, Alston CL, Blakely EL, Hepplewhite PD, Riordan G, Meldau S, Chinnery PF, Pierre G, Chronopoulou E, Du A, Hughes I, Morris AA, Kamakari S, Chrousos G, Rodenburg RJ, Saris CGJ, Feeney C, Hardy SA, Sakakibara T, Sudo A, Okazaki Y, Murayama K, Mundy H, Hanna MG, Ohtake A, Schaefer AM, Champion MP, Turnbull DM, Taylor RW, Pitceathly RDS, McFarland R, Gorman GS.

EBioMedicine. 2018 Apr;30:86-93. doi: 10.1016/j.ebiom.2018.02.010. Epub 2018 Feb 24.

6.

TIA1 variant drives myodegeneration in multisystem proteinopathy with SQSTM1 mutations.

Lee Y, Jonson PH, Sarparanta J, Palmio J, Sarkar M, Vihola A, Evilä A, Suominen T, Penttilä S, Savarese M, Johari M, Minot MC, Hilton-Jones D, Maddison P, Chinnery P, Reimann J, Kornblum C, Kraya T, Zierz S, Sue C, Goebel H, Azfer A, Ralston SH, Hackman P, Bucelli RC, Taylor JP, Weihl CC, Udd B.

J Clin Invest. 2018 Mar 1;128(3):1164-1177. doi: 10.1172/JCI97103. Epub 2018 Feb 19.

7.

Lambert-Eaton myasthenic syndrome and cerebellar ataxia: is Response to immunotherapy a clue to pathogenesis?

Ambrose PA, Maddison P.

Muscle Nerve. 2018 Jan 24. doi: 10.1002/mus.26079. [Epub ahead of print] No abstract available.

PMID:
29365352
8.

A diagnostic conundrum.

Keddie S, Jaunmuktane Z, Brandner S, Shah S, Maddison P, Rees JH, Hanna MG, Lunn MPT, Reilly MM, Rossor AM, Carr AS.

Pract Neurol. 2018 Apr;18(2):137-142. doi: 10.1136/practneurol-2017-001801. Epub 2018 Jan 23. No abstract available.

PMID:
29363556
9.

Latent class analysis of the health of the nation outcome scales: A comparison of Swiss and English profiles and exploration of their predictive utility.

Maddison P, Golay P, Muncer SJ.

Eur Psychiatry. 2018 Feb;48:1-5. doi: 10.1016/j.eurpsy.2017.10.006. Epub 2018 Jan 10. No abstract available.

PMID:
29331593
10.

Identification of GAA variants through whole exome sequencing targeted to a cohort of 606 patients with unexplained limb-girdle muscle weakness.

Johnson K, Töpf A, Bertoli M, Phillips L, Claeys KG, Stojanovic VR, Perić S, Hahn A, Maddison P, Akay E, Bastian AE, Łusakowska A, Kostera-Pruszczyk A, Lek M, Xu L, MacArthur DG, Straub V.

Orphanet J Rare Dis. 2017 Nov 17;12(1):173. doi: 10.1186/s13023-017-0722-1.

11.

The Association of British Neurologists' myasthenia gravis guidelines.

Sussman J, Farrugia ME, Maddison P, Hill M, Leite MI, Hilton-Jones D.

Ann N Y Acad Sci. 2018 Jan;1412(1):166-169. doi: 10.1111/nyas.13503. Epub 2017 Nov 9.

PMID:
29121404
12.

Ocular presentation of myasthenia gravis: A natural history cohort.

Kamarajah SK, Sadalage G, Palmer J, Carley H, Maddison P, Sivaguru A.

Muscle Nerve. 2018 Apr;57(4):622-627. doi: 10.1002/mus.25971. Epub 2017 Oct 6.

PMID:
28881457
13.

Authors' response to letter 'Long-term noninvasive ventilation in muscular dystrophy: Need planning of future services'.

Kinnear W, Colt J, Watson L, Smith P, Johnson L, Burrows S, Sovani M, Khanna A, Maddison P, Wills A.

Chron Respir Dis. 2017 May;14(2):196. doi: 10.1177/1479972316679681. No abstract available.

14.

The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research.

Wood L, Cordts I, Atalaia A, Marini-Bettolo C, Maddison P, Phillips M, Roberts M, Rogers M, Hammans S, Straub V, Petty R, Orrell R, Monckton DG, Nikolenko N, Jimenez-Moreno AC, Thompson R, Hilton-Jones D, Turner C, Lochmüller H.

J Neurol. 2017 May;264(5):979-988. doi: 10.1007/s00415-017-8483-2. Epub 2017 Apr 10.

15.

Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis.

Miller TD, Chong TT, Aimola Davies AM, Ng TWC, Johnson MR, Irani SR, Vincent A, Husain M, Jacob S, Maddison P, Kennard C, Gowland PA, Rosenthal CR.

Brain. 2017 May 1;140(5):1212-1219. doi: 10.1093/brain/awx070.

16.

Effects of aspirin on small-cell lung cancer mortality and metastatic presentation.

Maddison P.

Lung Cancer. 2017 Apr;106:67-69. doi: 10.1016/j.lungcan.2017.01.018. Epub 2017 Feb 4.

PMID:
28285696
17.

Long-term survival in paraneoplastic Lambert-Eaton myasthenic syndrome.

Maddison P, Gozzard P, Grainge MJ, Lang B.

Neurology. 2017 Apr 4;88(14):1334-1339. doi: 10.1212/WNL.0000000000003794. Epub 2017 Mar 1.

PMID:
28251917
18.

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.

Lang B, Makuch M, Moloney T, Dettmann I, Mindorf S, Probst C, Stoecker W, Buckley C, Newton CR, Leite MI, Maddison P, Komorowski L, Adcock J, Vincent A, Waters P, Irani SR.

J Neurol Neurosurg Psychiatry. 2017 Apr;88(4):353-361. doi: 10.1136/jnnp-2016-314758. Epub 2017 Jan 23.

19.

Body composition and clinical outcome measures in patients with myotonic dystrophy type 1.

Sedehizadeh S, Brook JD, Maddison P.

Neuromuscul Disord. 2017 Mar;27(3):286-289. doi: 10.1016/j.nmd.2016.11.005. Epub 2016 Nov 16.

PMID:
28082208
20.

Health Professionals' Perceptions of the Effects of Exercise on Joint Health in Rheumatoid Arthritis Patients.

Halls S, Law RJ, Jones JG, Markland DA, Maddison PJ, Thom JM.

Musculoskeletal Care. 2017 Sep;15(3):196-209. doi: 10.1002/msc.1157. Epub 2016 Oct 6.

PMID:
27709770
21.

Long-term non-invasive ventilation in muscular dystrophy.

Kinnear W, Colt J, Watson L, Smith P, Johnson L, Burrows S, Sovani M, Khanna A, Maddison P, Wills A.

Chron Respir Dis. 2017 Feb;14(1):33-36. doi: 10.1177/1479972316654285. Epub 2016 Jul 8.

22.

Tight control of disease activity fails to improve body composition or physical function in rheumatoid arthritis patients.

Lemmey AB, Wilkinson TJ, Clayton RJ, Sheikh F, Whale J, Jones HS, Ahmad YA, Chitale S, Jones JG, Maddison PJ, O'Brien TD.

Rheumatology (Oxford). 2016 Oct;55(10):1736-45. doi: 10.1093/rheumatology/kew243. Epub 2016 Jun 10.

PMID:
27288209
23.

Does an early home-based progressive resistance training program improve function following total hip replacement? Results of a randomized controlled study.

Okoro T, Whitaker R, Gardner A, Maddison P, Andrew JG, Lemmey A.

BMC Musculoskelet Disord. 2016 Apr 21;17:173. doi: 10.1186/s12891-016-1023-x.

24.

Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.

Gozzard P, Chapman C, Vincent A, Lang B, Maddison P.

PLoS One. 2015 Nov 25;10(11):e0143558. doi: 10.1371/journal.pone.0143558. eCollection 2015.

25.

Can Creatine Supplementation Improve Body Composition and Objective Physical Function in Rheumatoid Arthritis Patients? A Randomized Controlled Trial.

Wilkinson TJ, Lemmey AB, Jones JG, Sheikh F, Ahmad YA, Chitale S, Maddison PJ, O'brien TD.

Arthritis Care Res (Hoboken). 2016 Jun;68(6):729-37. doi: 10.1002/acr.22747.

26.

The frequency and outcome of lupus nephritis: results from an international inception cohort study.

Hanly JG, O'Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Fortin P, Gladman DD, Sanchez-Guerrero J, Petri M, Bruce IN, Dooley MA, Ramsey-Goldman R, Aranow C, Alarcón GS, Fessler BJ, Steinsson K, Nived O, Sturfelt GK, Manzi S, Khamashta MA, van Vollenhoven RF, Zoma AA, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Stoll T, Inanc M, Kalunian KC, Kamen DL, Maddison P, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell V.

Rheumatology (Oxford). 2016 Feb;55(2):252-62. doi: 10.1093/rheumatology/kev311. Epub 2015 Sep 5.

27.

Paraneoplastic neurologic disorders in small cell lung carcinoma: A prospective study.

Gozzard P, Woodhall M, Chapman C, Nibber A, Waters P, Vincent A, Lang B, Maddison P.

Neurology. 2015 Jul 21;85(3):235-9. doi: 10.1212/WNL.0000000000001721. Epub 2015 Jun 24.

28.

Autoantibodies to glutamic acid decarboxylase in patients with epilepsy and their relationship with type 1 diabetes: a pilot study.

Moloney TC, Idris I, Waters P, Howell S, Vincent A, Lang B, Maddison P.

J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):676-7. doi: 10.1136/jnnp-2015-310512. Epub 2015 May 20. No abstract available.

PMID:
25995487
29.

Myasthenia gravis: Association of British Neurologists' management guidelines.

Sussman J, Farrugia ME, Maddison P, Hill M, Leite MI, Hilton-Jones D.

Pract Neurol. 2015 Jun;15(3):199-206. doi: 10.1136/practneurol-2015-001126. Review.

PMID:
25977271
30.

The Effects of Aerobic and Resistance Exercise on Markers of Large Joint Health in Stable Rheumatoid Arthritis Patients: A Pilot Study.

Law RJ, Saynor ZL, Gabbitas J, Jones J, Kraus A, Breslin A, Maddison PJ, Thom JM.

Musculoskeletal Care. 2015 Dec;13(4):222-35. doi: 10.1002/msc.1103. Epub 2015 May 12.

PMID:
25962747
31.

Clinical and pathological features of mitochondrial DNA deletion disease following antiretroviral treatment.

Payne BA, Gardner K, Blakely EL, Maddison P, Horvath R, Taylor RW, Chinnery PF.

JAMA Neurol. 2015 May;72(5):603-5. doi: 10.1001/jamaneurol.2015.0150. No abstract available.

PMID:
25961175
32.

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial.

Scott DL, Ibrahim F, Farewell V, O'Keeffe AG, Walker D, Kelly C, Birrell F, Chakravarty K, Maddison P, Heslin M, Patel A, Kingsley GH.

BMJ. 2015 Mar 13;350:h1046. doi: 10.1136/bmj.h1046.

33.

Anti-C1q antibodies in systemic lupus erythematosus.

Orbai AM, Truedsson L, Sturfelt G, Nived O, Fang H, Alarcón GS, Gordon C, Merrill J, Fortin PR, Bruce IN, Isenberg DA, Wallace DJ, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke AE, Aranow CB, Manzi S, Urowitz MB, Gladman DD, Kalunian KC, Costner MI, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, Van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS, Petri M.

Lupus. 2015 Jan;24(1):42-9. doi: 10.1177/0961203314547791. Epub 2014 Aug 14.

34.

Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.

Carvajal-González A, Leite MI, Waters P, Woodhall M, Coutinho E, Balint B, Lang B, Pettingill P, Carr A, Sheerin UM, Press R, Lunn MP, Lim M, Maddison P, Meinck HM, Vandenberghe W, Vincent A.

Brain. 2014 Aug;137(Pt 8):2178-92. doi: 10.1093/brain/awu142. Epub 2014 Jun 20. Erratum in: Brain. 2014 Dec;137(Pt 12):e315. Press, Raomand [corrected to Press, Rayomand].

35.

Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosus.

Urowitz M, Gladman DD, Ibañez D, Sanchez-Guerrero J, Bae SC, Gordon C, Fortin PR, Clarke A, Bernatsky S, Hanly JG, Wallace DJ, Isenberg D, Rahman A, Merrill J, Ginzler E, Alarcón GS, Fessler B, Khamashta M, Steinsson K, Petri M, Dooley M, Bruce IN, Manzi S, Sturfelt G, Nived O, Ramsey-Goldman R, Zoma A, Maddison P, Kalunian K, van Vollenhoven R, Aranow C, Romero Diaz J, Stoll T.

Arthritis Care Res (Hoboken). 2014 Sep;66(9):1374-9. doi: 10.1002/acr.22299.

36.

A simple step test to estimate cardio-respiratory fitness levels of rheumatoid arthritis patients in a clinical setting.

Cooney JK, Moore JP, Ahmad YA, Jones JG, Lemmey AB, Casanova F, Maddison PJ, Thom JM.

Int J Rheumatol. 2013;2013:174541. doi: 10.1155/2013/174541. Epub 2013 Dec 23.

37.

Limbic encephalitis and Lambert Eaton myasthenic syndrome--an immunological profile of a new syndrome.

Kalra S, Gozzard P, Jacob S, Leonard A, Maddison P.

Clin Neurol Neurosurg. 2014 Jan;116:99-100. doi: 10.1016/j.clineuro.2013.10.014. Epub 2013 Oct 31. No abstract available.

PMID:
24269050
38.

A multicentre postal survey investigating the contribution of illness perceptions, coping and optimism to quality of life and mood in adults with muscle disease.

Graham CD, Weinman J, Sadjadi R, Chalder T, Petty R, Hanna MG, Turner C, Parton M, Maddison P, Radunovic A, Longman C, Robb Y, Bushby K, Hilton-Jones D, Rose MR.

Clin Rehabil. 2014 May;28(5):508-19. doi: 10.1177/0269215513511340. Epub 2013 Nov 15.

PMID:
24240060
39.

Myasthenia gravis and pregnancy: pressing time for best practice guidelines.

Maddison P.

J Neurol Neurosurg Psychiatry. 2014 May;85(5):477. doi: 10.1136/jnnp-2013-305777. Epub 2013 Jul 11. No abstract available.

PMID:
23847286
40.

Patellar tendon properties and lower limb function in rheumatoid arthritis and ankylosing spondylitis versus healthy controls: a cross-sectional study.

Matschke V, Jones JG, Lemmey AB, Maddison PJ, Thom JM.

ScientificWorldJournal. 2013 Jun 5;2013:514743. doi: 10.1155/2013/514743. Print 2013.

41.

ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation.

Sarkozy A, Hicks D, Hudson J, Laval SH, Barresi R, Hilton-Jones D, Deschauer M, Harris E, Rufibach L, Hwang E, Bashir R, Walter MC, Krause S, van den Bergh P, Illa I, Pénisson-Besnier I, De Waele L, Turnbull D, Guglieri M, Schrank B, Schoser B, Seeger J, Schreiber H, Gläser D, Eagle M, Bailey G, Walters R, Longman C, Norwood F, Winer J, Muntoni F, Hanna M, Roberts M, Bindoff LA, Brierley C, Cooper RG, Cottrell DA, Davies NP, Gibson A, Gorman GS, Hammans S, Jackson AP, Khan A, Lane R, McConville J, McEntagart M, Al-Memar A, Nixon J, Panicker J, Parton M, Petty R, Price CJ, Rakowicz W, Ray P, Schapira AH, Swingler R, Turner C, Wagner KR, Maddison P, Shaw PJ, Straub V, Bushby K, Lochmüller H.

Hum Mutat. 2013 Aug;34(8):1111-8. doi: 10.1002/humu.22342. Epub 2013 Jun 12.

PMID:
23606453
42.

What does standard rehabilitation practice after total hip replacement in the UK entail? Results of a mixed methods study.

Okoro T, Ramavath A, Howarth J, Jenkinson J, Maddison P, Andrew JG, Lemmey A.

BMC Musculoskelet Disord. 2013 Mar 12;14:91. doi: 10.1186/1471-2474-14-91.

43.

An assessment of the impact of behavioural cognitions on function in patients partaking in a trial of early home-based progressive resistance training after total hip replacement surgery.

Okoro T, Morrison V, Maddison P, Lemmey AB, Andrew JG.

Disabil Rehabil. 2013;35(23):2000-7. doi: 10.3109/09638288.2013.770082. Epub 2013 Mar 13.

PMID:
23480673
44.

A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene.

Løseth S, Voermans NC, Torbergsen T, Lillis S, Jonsrud C, Lindal S, Kamsteeg EJ, Lammens M, Broman M, Dekomien G, Maddison P, Muntoni F, Sewry C, Radunovic A, de Visser M, Straub V, van Engelen B, Jungbluth H.

J Neurol. 2013 Jun;260(6):1504-10. doi: 10.1007/s00415-012-6817-7. Epub 2013 Jan 18.

PMID:
23329375
45.

Treatment in Lambert-Eaton myasthenic syndrome.

Maddison P.

Ann N Y Acad Sci. 2012 Dec;1275:78-84. doi: 10.1111/j.1749-6632.2012.06769.x. Review.

PMID:
23278581
46.

Perceptions of issues relating to exercise and joint health in rheumatoid arthritis: a UK-based questionnaire study.

Law RJ, Markland DA, Jones JG, Maddison PJ, Thom JM.

Musculoskeletal Care. 2013 Sep;11(3):147-58. doi: 10.1002/msc.1037. Epub 2012 Nov 5.

PMID:
23125122
47.

Clinical and myopathological characteristics of desminopathy caused by a mutation in desmin tail domain.

Maddison P, Damian MS, Sewry C, McGorrian C, Winer JB, Odgerel Z, Shatunov A, Lee HS, Goldfarb LG.

Eur Neurol. 2012;68(5):279-86. doi: 10.1159/000341617. Epub 2012 Oct 5.

48.

The use of aminopyridines in neurological disorders.

Sedehizadeh S, Keogh M, Maddison P.

Clin Neuropharmacol. 2012 Jul-Aug;35(4):191-200. doi: 10.1097/WNF.0b013e31825a68c5. Review.

PMID:
22805230
49.

Neuronal antibodies and paraneoplastic sensory neuropathy in thymoma.

Barua A, Gozzard P, Martin-Ucar AE, Maddison P.

Interact Cardiovasc Thorac Surg. 2012 Sep;15(3):516-7. doi: 10.1093/icvts/ivs207. Epub 2012 May 22.

50.

Baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis.

Barnes T, Gliddon A, Doré CJ, Maddison P, Moots RJ; QUINs Trial Study Group.

Rheumatology (Oxford). 2012 Sep;51(9):1606-9. Epub 2012 May 16.

Supplemental Content

Loading ...
Support Center